OrthoPediatrics Corp. (KIDS)
NASDAQ: KIDS · Real-Time Price · USD
21.02
-0.70 (-3.22%)
Jun 13, 2025, 3:45 PM - Market open
OrthoPediatrics Stock Forecast
Stock Price Forecast
According to 7 professional analysts, the 12-month price target for OrthoPediatrics stock ranges from a low of $24 to a high of $50. The average analyst price target of $35.71 forecasts a 69.89% increase in the stock price over the next year.
Price Target: $35.71 (+69.89%)
Analyst Consensus: Buy
* Price targets were last updated on May 8, 2025.
Analyst Ratings
The average analyst rating for OrthoPediatrics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 1 | 2 | 2 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $30 | Buy | Maintains | $40 → $30 | +42.72% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +99.81% | May 8, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $26 → $24 | Hold | Maintains | $26 → $24 | +14.18% | Apr 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +99.81% | Apr 9, 2025 |
| Lake Street | Lake Street | Strong Buy Initiates $37 | Strong Buy | Initiates | $37 | +76.02% | Apr 7, 2025 |
Financial Forecast
Revenue This Year
244.09M
from 204.73M
Increased by 19.23%
Revenue Next Year
285.92M
from 244.09M
Increased by 17.14%
EPS This Year
-1.29
from -1.64
EPS Next Year
-1.02
from -1.29
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 252.2M | 300.7M | 356.3M |
| Avg | 244.1M | 285.9M | 334.5M |
| Low | 232.8M | 269.9M | 309.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 23.2% | 23.2% | 24.6% |
| Avg | 19.2% | 17.1% | 17.0% |
| Low | 13.7% | 10.6% | 8.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.17 | -0.60 | 0.01 |
| Avg | -1.29 | -1.02 | -0.72 |
| Low | -1.37 | -1.21 | -1.06 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.